• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腙、苯腙和异烟酰腙作为潜在的抗结核药物。

Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.

机构信息

Postgraduate Program in Health Sciences, State University of Maringá, Maringá, Paraná, 87020-900, Brazil.

Postgraduate Program in Bioscience & Physiopathology, State University of Maringá, Maringá, Paraná, 87020-900, Brazil.

出版信息

Future Microbiol. 2019 Jul;14:981-994. doi: 10.2217/fmb-2019-0040. Epub 2019 Aug 6.

DOI:10.2217/fmb-2019-0040
PMID:31382801
Abstract

To evaluate the potential of three benzohydrazones (-), four acylhydrazones derived from isoniazid (INH-acylhydrazones) (-) and one hydrazone () as antituberculosis agents. Inhibitory and bactericidal activities were determined for the reference () strain and clinical isolates. Cytotoxicity, drug combinations and ethidium bromide accumulation assays were also performed. The tested compounds (-) presented excellent antituberculosis activity with surprisingly inhibitory (0.12-250 μg/ml) and bactericidal values, even against multidrug-resistant clinical isolates. Compounds showed high selectivity index, with values reaching 1833.33, and a limited spectrum of activity. Some of the compounds ( & ) are also great inhibitors of bacillus efflux pumps. Benzohydrazones and INH-acylhydrazones may be considered scaffolds for the development of new anti- drugs.

摘要

为了评估三种苯腙(-)、四种异烟酰腙(INH-酰腙)(-)和一种腙()作为抗结核药物的潜力。对参考()株和临床分离株进行了抑制和杀菌活性的测定。还进行了细胞毒性、药物组合和溴化乙锭积累测定。 测试化合物(-)表现出优异的抗结核活性,令人惊讶的是具有抑制(0.12-250μg/ml)和杀菌作用,甚至对耐多药临床分离株也有作用。化合物具有高选择性指数,值可达 1833.33,且活性范围有限。一些化合物(&)也是芽孢杆菌外排泵的有效抑制剂。 苯腙和 INH-酰腙可能被认为是开发新型抗结核药物的支架。

相似文献

1
Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.腙、苯腙和异烟酰腙作为潜在的抗结核药物。
Future Microbiol. 2019 Jul;14:981-994. doi: 10.2217/fmb-2019-0040. Epub 2019 Aug 6.
2
Isoniazid-N-acylhydrazones as promising compounds for the anti-tuberculosis treatment.异烟肼酰腙类化合物有望成为抗结核治疗的新化合物。
Tuberculosis (Edinb). 2023 Jul;141:102363. doi: 10.1016/j.tube.2023.102363. Epub 2023 Jun 6.
3
The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against .将腙基、酰腙或氮杂环丁烷部分引入三萜核可增强其对. 的活性。
Med Chem. 2021;17(2):134-145. doi: 10.2174/1573406416666200115161700.
4
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.一类新型异烟酰腙单独及与异烟肼、利福平、乙胺丁醇、对氨基水杨酸和氯法齐明联合使用对结核分枝杆菌的活性。
J Antimicrob Chemother. 2002 Feb;49(2):275-82. doi: 10.1093/jac/49.2.275.
5
and Evaluations of Anti- Activity of Benzohydrazones Compounds.并评估苯甲酰肼类化合物的抗活性。
Microb Drug Resist. 2021 Nov;27(11):1564-1577. doi: 10.1089/mdr.2020.0392. Epub 2021 Apr 28.
6
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.新型异烟肼衍生物的机械化学合成及抗结核活性的生物学评价。
Molecules. 2017 Sep 1;22(9):1457. doi: 10.3390/molecules22091457.
7
Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against .合成及生物评价新型(-)-莰烯基 1,3,4-噻二唑类化合物对.的抑制活性
Future Microbiol. 2020 Jun;15:723-738. doi: 10.2217/fmb-2019-0258. Epub 2020 Jul 20.
8
Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.新型噻吗啉连接的色酮腙作为潜在的耐药结核分枝杆菌抑制剂。
Bioorg Chem. 2021 Oct;115:105133. doi: 10.1016/j.bioorg.2021.105133. Epub 2021 Jul 3.
9
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.具有强效抗结核活性的新型异烟肼衍生物的设计、合成及生物学评价
Eur J Med Chem. 2014 Jun 23;81:119-38. doi: 10.1016/j.ejmech.2014.04.077. Epub 2014 Apr 29.
10
Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.基于4-喹啉腙支架的抗结核化合物的研发。进一步的构效关系研究。
Bioorg Med Chem. 2009 Aug 15;17(16):6063-72. doi: 10.1016/j.bmc.2009.06.051. Epub 2009 Jun 27.

引用本文的文献

1
A new -acylhydrazone oxadiazole derivative with activity against mycobacteria.一种对分枝杆菌具有活性的新型酰腙恶二唑衍生物。
Future Microbiol. 2025 Jan;20(1):33-44. doi: 10.1080/17460913.2024.2412439. Epub 2024 Oct 23.
2
Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents.硝基喹诺酮稠合酰腙作为非小细胞肺癌药物的抗增殖活性。
RSC Med Chem. 2023 May 17;14(7):1331-1343. doi: 10.1039/d3md00165b. eCollection 2023 Jul 20.
3
Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA.
基于酰肼-腙和噻二唑衍生物靶向InhA的抗结核药物发现的最新进展
Pharmaceuticals (Basel). 2023 Mar 23;16(4):484. doi: 10.3390/ph16040484.
4
In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents.新型芳酰腙衍生物作为抗结核药物的体内毒性、氧化还原调节能力及肠道通透性
Pharmaceutics. 2022 Dec 26;15(1):79. doi: 10.3390/pharmaceutics15010079.